Selegiline, also known as R-deprenyl (Jumex®; Fig. 1), is a registered, irreversible and selective monoamine oxidase B (MAO-B) enzyme inhibitor [20] found to be effective and well-tolerated in the treatment of Parkinson’s disease (PD) and depression [21–23]. The gene discussed is MAOB; the disease is depressive symptom measurement.